Particular histological features of a case of Sweet's syndrome induced by G-CSF;Particularités histologiques d'un cas de syndrome de Sweet déclenché par le G-CSF

Annales de Dermatologie et de Venereologie

Volumn 131, Issue 4, 2004, Pages 369-372

  Abecassis, S ^a   Ingen Housz Oro, S ^a,b   Cavelier Balloy, B ^a   Arnulf, B ^a   Bachelez, H ^a   Dubertret, L ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b CENTRE HOSPITALIER VICTOR DUPOUY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE FEBRILE NEUTROPHILIC DERMATOSIS; ADULT; ANGIOGENESIS; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BLOOD DISEASE; CANCER CHEMOTHERAPY; CASE REPORT; CORTICOSTEROID THERAPY; DRUG ERUPTION; EDEMA; ERYTHEMA; FEVER; HISTIOCYTE; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MULTIPLE MYELOMA; NEUTROPHIL CHEMOTAXIS; RASH; SKIN BIOPSY;

EID: 2342587506     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0151-9638(04)93617-4     Document Type: Article

References (22)

1. Van Den Driesch P. Sweet's syndrome (acute febrile neutrophilic dermatosis). J Am Acad Dermatol 1994;31:531-56.
2. Milpied N, Harousseau JL, Castaigne S, Bureau B, Reynaud C, Rodat O. Lésions évoquant un syndrome de Sweet au cours d'une leucémie aiguë: survenue pendant la phase d'aplasie thérapeutique. Ann Med Interne 1983;134:38-41.
3. Torri O, Ruto F, Dierick A, Labeille B, Lok C, Desablens B et al. Dermatose aiguë fébrile neutrophilique (syndrome de Sweet) en période d'agranulocytose thérapeutique au cours d'une leucémie aiguë myéloblastique (LAM). Ann Dermatol Venereol 1993;120:884-8.
4. Probert C, Ehmann C, Al-Mondhiry H, Ballard J, Helm KF. Sweet's syndrome without granulocytosis. Int J Dermatol 1998;37:108-12.
5. Aractingi S, Mallet V, Pinquier L, Chosidow O, Vignon-Pennamen MD, Degos L et al. Neutrophilic dermatoses during granulocytopenia. Arch Dermatol 1995;131:1141-5.
6. Chao SC, Lee YY, Tsao CJ. Sweet's syndrome in a severely neutropenic patient during therapy with recombinant human granulocyte colony-stimulating factor. J Formos Med Assoc 1997;96:276-9.
7. Fukutoku M, Shimizu S, Ogawa Y, Takeshita S, Masaki Y, Arai T et al. Sweet's syndrome during therapy with granulocyte colony-stimulating factor in a patient with aplastic anaemia. Br J Haematol 1994;86:645-8.
8. Hasegawa M, Sato S, Nakada M, Nitta H, Shirasaki H, Kasahara K et al. Sweet's syndrome associated with granulocyte colony-stimulating factor. Eur J Dermatol 1998;8:503-5.
9. Paydas S, Sahim B, Seyrek E, Soylu M, Gonlusen G, Acar A et al. Sweet's syndrome associated with G-CSF. Br J Haematol 1993;85:191-2.
10. Bayer-Garner IB, Cottler-Fox M, Smoller BR. Sweet syndrome in multiple myeloma: a series of six cases. J Cutan Pathol 2003;39:261-4.
11. Delabie J, De Wolf-Peeters C, Morren M, Marien K, Roskams T, Desmet V. Histiocytes in Sweet's syndrome. Br J Dermatol 1991;124:348-53.
12. Fariña MC, Requena L, Dómine M, Soriano ML, Estevez L, Barat A. Histopathology of cutaneous reaction to granulocyte colony-stimulating factor: another pseudo-malignancy. J Cutan Pathol 1998;25:559-62.
13. Glass LF, Fotopoulos T, Messina JL. A generalized cutaneous reaction induced by granulocyte colony-stimulating factor. J Am Acad Dermatol 1996;34:455-9.
14. Scott GA. Report of three cases of cutaneous reactions to granulocyte macrophage-colony-stimulating factor and a review of the literature. Am J Dermatopathol 1995;17:107-14.
15. Horn TD, Burke PJ, Karp JE, Hood AF. Intravenous administration of recombinant human granulocyte-macrophage colony-stimulating factor causes a cutaneous eruption. Arch Dermatol 1991;127:49-52.
16. Valks R, Vargas E, Muñoz E, Fernández-Herrera J, Garcia-Diéz A, Fraga J. Dermal infiltrate of enlarged macrophages in patients receiving chemotherapy. J Cutan Pathol 1998;25:259-64.
17. Bussolino F, Ziche M, Wang JM, Alessi D, Morbidelli L, Cremona O et al. In vitro and in vivo activation of endothelial cells by colony-stimulating factors. J Clin Invest 1991;87:986-95.
18. Ross HJ, Moy LA, Kaplan R, Figlin RA. Bullous pyoderma gangrenosum after granulocyte colony-stimulating factor treatment. Cancer 1991;68:441-3.
19. Bachmeyer C, Chaibi P, Aractingi S. Neutrophilic eccrine hidradenitis induced by granulocyte colony-stimulating factor. Br J Dermatol 1998;139:340-61.
20. Samlaska CP, Noyes DK. Localized cutaneous reactions to granulocyte colony-stimulating factor. Arch Dermatol 1993;129:645-6.
21. Ostlere LS, Harris D, Prentice HG, Rustin MHA. Widespread folliculitis induced by human granulocyte-colony-stimulating factor therapy. Br J Dermatol 1992;127:193-4.
22. Jain KK. Cutaneous vasculitis associated with granulocyte colony-stimulating factor. J Am Acad Dermatol 1994;31:213-5.